申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US05532258A1
公开(公告)日:1996-07-02
Thiazole compounds of formula ##STR1## are provided which have antiulcer activity and H.sub.2 -receptor antagonism, wherein R.sup.2 is lower alkyl or lower alkoxy(lower)alkyl, R.sup.3 is hydrogen, A is methylene and R.sup.1 is lower alkyl.
提供具有抗溃疡活性和H.sub.2-受体拮抗作用的式为##STR1##的噻唑化合物,其中R.sup.2是低级烷基或低级烷氧基(低级)烷基,R.sup.3是氢,A是亚甲基,R.sup.1是低级烷基。